Myovant Sciences Ltd. Uncategorized Contracts & Agreements
17 Contracts & Agreements
- Letter Agreement by and between Myovant Sciences GmbH and Pfizer, Inc. dated September 19, 2022 (Filed With SEC on October 26, 2022)
- Amendment No.1 to Myovant Sciences Ltd. 2020 Inducement Plan (Filed With SEC on March 25, 2022)
- Letter Agreement, dated July 27, 2021, by and between Myovant Sciences GmbH and Pfizer, Inc (Filed With SEC on October 26, 2021)
- Letter Agreement (Filed With SEC on July 28, 2021)
- Commitment Letter Amendment Letter, dated December 22, 2020, by and between Sumitomo Dainippon Pharma Co., Ltd. and the Registrant (Filed With SEC on February 11, 2021)
- Form of Option Grant Notice and Option Agreement under 2020 Inducement Plan (Filed With SEC on November 12, 2020)
- 2020 Inducement Plan (Filed With SEC on November 12, 2020)
- Commitment Letter Amendment Letter (Filed With SEC on November 12, 2020)
- Commitment Letter, dated August 5, 2020, by and between Sumitomo Dainippon Pharma Co., Ltd. and the Registrant (Filed With SEC on November 12, 2020)
- Description of Common Shares (Filed With SEC on May 18, 2020)
- Letter Agreement, dated October 31, 2019, by and between the Registrant and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on February 10, 2020)
- LICENSEAGREEMENT by and between TAKEDA PHARMACEUTICALS INTERNATIONAL AG and ROIVANT ENDOCRINOLOGY LTD. Dated as of April 29, 2016 (Filed With SEC on October 25, 2016)
- RIGHT OF FIRST NEGOTIATION AND BOARDOBSERVER AGREEMENT (Filed With SEC on October 24, 2016)
- LICENSEAGREEMENT by and between TAKEDA PHARMACEUTICALS INTERNATIONAL AG and ROIVANT ENDOCRINOLOGY LTD. Dated as of April 29, 2016 (Filed With SEC on October 20, 2016)
- Myovant Sciences,Inc. 2000 Sierra Point Parkway, Suite 550, Brisbane, CA 94005 myovant.com (Filed With SEC on September 30, 2016)
- OPTION AGREEMENT (Filed With SEC on September 30, 2016)
- LICENSEAGREEMENT by and between TAKEDA PHARMACEUTICALS INTERNATIONAL AG and ROIVANT ENDOCRINOLOGY LTD. Dated as of April 29, 2016 (Filed With SEC on September 30, 2016)
